HXHX:NASDAQHaoxin Holdings Limited analysis
Data as of Jun 7, 2026 - not real-time
- Latest price
- $0.45
- Risk: high
- 9/10High risk
Summary
Haoxin Holdings is trading well below its short‑, medium‑ and long‑term moving averages, with the price sitting near the identified support level of $0.37 and a bearish MACD crossover confirming downward momentum. Technical indicators such as a sub‑50 RSI and a bearish MACD, combined with an 84% 30‑day volatility and a beta of nearly 2.8, signal a highly volatile and risky short‑term outlook.
Fundamentally, the stock appears deeply undervalued – a trailing PE of roughly 1.5 versus an industry average above 30 – but this discount reflects severe financial strain: negative operating and free cash flow, a debt‑to‑equity ratio exceeding 40, and a massive historical drawdown of about 80%. No dividend is paid and cash balances are minimal, further limiting defensive appeal.
Fundamentally, the stock appears deeply undervalued – a trailing PE of roughly 1.5 versus an industry average above 30 – but this discount reflects severe financial strain: negative operating and free cash flow, a debt‑to‑equity ratio exceeding 40, and a massive historical drawdown of about 80%. No dividend is paid and cash balances are minimal, further limiting defensive appeal.
Market outlook
Short term
< 1 yearCautious
Model confidence8/108 out of 10
Key factors
- Price below all key moving averages and near support
- Bearish MACD and neutral‑to‑low RSI
- Extreme volatility and high beta amplifying downside risk
Medium term
1–3 yearsNeutral
Model confidence5/105 out of 10
Key factors
- Significant valuation discount relative to peers
- Potential upside if debt restructuring or cash‑flow improvement occurs
- Continued high leverage and negative cash flow keep risk elevated
Long term
> 3 yearsNeutral
Model confidence4/104 out of 10
Key factors
- Deep value metrics could attract speculative interest
- Structural challenges in Chinese logistics and regulatory environment
- Absence of dividend and ongoing financial distress limit long‑term appeal
Key metrics
Financial health
Revenue Growth-6.50%
Profit Margin12.01%
P/E Ratio1.5
ROE17.25%
ROA11.78%
Debt/Equity42.24
P/B Ratio0.2
Op. Cash Flow$-9546215
Free Cash Flow$-12345349
Industry P/E30.2
Technical analysis
TrendBearish
RSI46.0
Support$0.37
Resistance$0.65
MA 20$0.45
MA 50$0.51
MA 200$0.70
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02
Valuation
GradeUndervalued
TypeValue
Risk assessment
Beta2.79
Volatility84.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.